In a filing, BioCardia Inc revealed its President and CEO Altman Peter acquired Company’s shares for reported $1281.0 on Aug 22 ’25. In the deal valued at $1.83 per share,700 shares were bought. As a result of this transaction, Altman Peter now holds 168,762 shares worth roughly $0.19 million.
Then, Altman Peter bought 100 shares, generating $183 in total proceeds. Upon buying the shares at $1.83, the President and CEO now owns 168,062 shares.
Before that, Altman Peter bought 400 shares. BioCardia Inc shares valued at $700 were divested by the President and CEO at a price of $1.75 per share. As a result of the transaction, Altman Peter now holds 167,962 shares, worth roughly $0.19 million.
Dawson James downgraded its BioCardia Inc [BCDA] rating to a Neutral from a a Buy in a research note published recently.
Price Performance Review of BCDA
On Monday, BioCardia Inc [NASDAQ:BCDA] saw its stock fall -4.31% to $1.11. Over the last five days, the stock has lost -48.37%. BioCardia Inc shares have fallen nearly -63.96% since the year began. Nevertheless, the stocks have fallen -49.08% over the past one year. While a 52-week high of $3.20 was reached on 04/29/25, a 52-week low of $1.00 was recorded on 09/18/25.
Levels Of Support And Resistance For BCDA Stock
The 24-hour chart illustrates a support level at 1.0833, which if violated will result in even more drops to 1.0567. On the upside, there is a resistance level at 1.1533. A further resistance level may holdings at 1.1967.
How much short interest is there in BioCardia Inc?
A steep rise in short interest was recorded in BioCardia Inc stocks on 2025-08-29, growing by 0.12 million shares to a total of 0.21 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 88826.0 shares. There was a rise of 57.58%, which implies that there is a positive sentiment for the stock.
